Please wait...
Börse Frankfurt

Fresenius Medical Care AG & Co. KGaA St

Equity, ISIN DE0005785802, WKN 578580, FME

Prime Standard

This section contains not only general information but also information dealing with the company's follow-up obligations as part of the membership in a certain transparency standard at Börse Frankfurt, FWB, the Frankfurt Stock Exchange. This mandatory information is marked with an asterisk. Learn more about what information is required depending on transparency standard and asset class on xetra.com.

Address

Address Fresenius Medical Care AG & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg
Deutschland
Phone +49 (0)6172 609-2525
Fax +49 (0)6172 609-2301
URL http://www.fmc-ag.com/
Email ir@fmc-ag.com

About the Company

Fresenius Medical Care is the world's largest integrated provider of products and services for individuals undergoing dialysis because of chronic kidney failure, a condition that affects more than 2.1 million individuals worldwide. Through its network of 3,135 dialysis clinics in North America, Europe, Latin America, Asia-Pacific and Africa, Fresenius Medical Care provides dialysis treatment to 256,521 patients around the globe. Fresenius Medical Care is also the world's leading provider of dialysis products such as hemodialysis machines, dialyzers and related disposable products. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME, FME3) and the New York Stock Exchange (FMS, FMS/P).

Corporate Information

Established 1996
Transparency Standard Prime Standard
Market Segment Regulated Market
End of Business Year 31/12/
Accounting Standard US-GAAP
Total Capital Stock € 307,193,719.00
Admission Date 02/10/1996
Executive Board (represented by: Fresenius Medical Care Management AG, general partner of Fresenius Medical Care AG & Co. KGaA)
Rice Powell (Chairman), Michael Brosnan (Finance), Roberto Fusté (Asia-Pacific), Dr. Emanuele Gatti (Europe, Middle East, Africa and Latin America and Global Chief Strategist), Ronald Kuerbitz (North America), Dr. Rainer Runte (Global Law, Compliance, Intellectual Property, Corporate Business Development, and Labor Relations Director Germany), Kent Wanzek (Production)
Supervisory Board Dr. Gerd Krick (Chairman), Dr. Dieter Schenk (Vice Chairman), Rolf A. Classon, Prof. Dr. Bernd Fahrholz, Dr. William P. Johnston, Dr. Walter L. Weisman
Period Title Download Comment Comment
01/01/2013 till 31/03/2013 Three-month statement PDF

Please note: The report titles may differ from the denominations in the rules and regulations for Frankfurt Wertpapierbörse (FWB®, the Frankfurt Stock Exchange).

Shareholder Structure Bearer shares without par value ISIN DE0005785802

Shareholder Current Shares in %
Fresenius SE & Co. KGaA 31.17
Thornburg Investment Management Inc 5.003
BlackRock, Inc., New York 4.97

Dividend

Last Payment Date Dividend Cycle Amount ISIN
17/05/2013 Annually € 0.75 DE0005785802
17/05/2013 Annually € 0.77 DE0005785836
11/05/2012 Annually € 0.69 DE0005785802
11/05/2012 Annually € 0.71 DE0005785836
13/05/2011 Annually € 0.65 DE0005785802
13/05/2011 Annually € 0.67 DE0005785836
12/05/2010 Annually € 0.61 DE0005785802
12/05/2010 Annually € 0.63 DE0005785836
08/05/2009 Annually € 0.58 DE0005785802
08/05/2009 Annually € 0.60 DE0005785836
Results 1 - 10 of 24

IPO Company Data

No data available on this website.

* Please note: Companies may address supplementary questions regarding the submission of mandatory data marked with an * by sending an e-mail to: stammdaten@deutsche-boerse.com, phone: +49-(0) 69-2 11-1 31 87.

Advertisement

Do you have questions or comments about this web site?